Literature DB >> 15868128

[Magnetic drug targeting. New paths for the local concentration of drugs for head and neck cancer].

C Simon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15868128     DOI： 10.1007/s00106-005-1278-2

Source DB:  PubMed          Journal:  HNO        ISSN： 0017-6192            Impact factor:   1.284


× No keyword cloud information.
  16 in total

1.  Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

Authors:  Jacques Bernier; Christian Domenge; Mahmut Ozsahin; Katarzyna Matuszewska; Jean-Louis Lefèbvre; Richard H Greiner; Jordi Giralt; Philippe Maingon; Frédéric Rolland; Michel Bolla; Francesco Cognetti; Jean Bourhis; Anne Kirkpatrick; Martine van Glabbeke
Journal:  N Engl J Med       Date:  2004-05-06       Impact factor: 91.245

2.  Locoregional cancer treatment with magnetic drug targeting.

Authors:  C Alexiou; W Arnold; R J Klein; F G Parak; P Hulin; C Bergemann; W Erhardt; S Wagenpfeil; A S Lübbe
Journal:  Cancer Res       Date:  2000-12-01       Impact factor: 12.701

3.  Employment of magnet-susceptible microparticles for the targeting of drugs.

Authors:  D A Kharkevich; R N Alyautdin; V I Filippov
Journal:  J Pharm Pharmacol       Date:  1989-04       Impact factor: 3.765

4.  Magnetic drug targeting--biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment.

Authors:  Christoph Alexiou; Roland Jurgons; Roswitha J Schmid; Christian Bergemann; Julia Henke; Wolf Erhardt; Ernst Huenges; Fritz Parak
Journal:  J Drug Target       Date:  2003-04       Impact factor: 5.121

5.  Preclinical experiences with magnetic drug targeting: tolerance and efficacy.

Authors:  A S Lübbe; C Bergemann; W Huhnt; T Fricke; H Riess; J W Brock; D Huhn
Journal:  Cancer Res       Date:  1996-10-15       Impact factor: 12.701

6.  Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.

Authors:  A S Lübbe; C Bergemann; H Riess; F Schriever; P Reichardt; K Possinger; M Matthias; B Dörken; F Herrmann; R Gürtler; P Hohenberger; N Haas; R Sohr; B Sander; A J Lemke; D Ohlendorf; W Huhnt; D Huhn
Journal:  Cancer Res       Date:  1996-10-15       Impact factor: 12.701

7.  Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia.

Authors:  Akira Ito; Yuko Kuga; Hiroyuki Honda; Hiroyuki Kikkawa; Atsushi Horiuchi; Yuji Watanabe; Takeshi Kobayashi
Journal:  Cancer Lett       Date:  2004-08-30       Impact factor: 8.679

8.  In vitro release of biologically active adriamycin by magnetically responsive albumin microspheres.

Authors:  K J Widder; A E Senyei; D F Ranney
Journal:  Cancer Res       Date:  1980-10       Impact factor: 12.701

9.  Evaluation of systemic chemotherapy with magnetic liposomal doxorubicin and a dipole external electromagnet.

Authors:  Hiroo Nobuto; Takashi Sugita; Tadahiko Kubo; Shoji Shimose; Yuji Yasunaga; Teruo Murakami; Mitsuo Ochi
Journal:  Int J Cancer       Date:  2004-04-20       Impact factor: 7.396

10.  [Magnetic Drug Targeting--a new approach in locoregional tumor therapy with chemotherapeutic agents. Experimental animal studies].

Authors:  C Alexiou; R Jurgons; R Schmid; W Erhardt; F Parak; C Bergemann; H Iro
Journal:  HNO       Date:  2005-07       Impact factor: 1.284
View more
  2 in total

1.  The Behaviors of Ferro-Magnetic Nano-Particles In and Around Blood Vessels under Applied Magnetic Fields.

Authors:  A Nacev; C Beni; O Bruno; B Shapiro
Journal:  J Magn Magn Mater       Date:  2011-03-01       Impact factor: 2.993

2.  Planar Steering of a Single Ferrofluid Drop by Optimal Minimum Power Dynamic Feedback Control of Four Electromagnets at a Distance.

Authors:  R Probst; J Lin; A Komaee; A Nacev; Z Cummins; B Shapiro
Journal:  J Magn Magn Mater       Date:  2011-04-01       Impact factor: 2.993
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.